Hoffmann-La Roche Newswire

Comprehensive Real-Time News Feed for Hoffmann-La Roche.

Results 1 - 20 of 50 in Hoffmann-La Roche

  1. Google 'anti-aging' group Calico has a websiteRead the original story w/Photo

    Wednesday Aug 13 | New York Daily News

    ... not been previously announced, include Hall Barron former chief medical officer of pharmaceutical group Hoffmann-La Roche; David Botstein, a Princeton University genomics professor; and Cynthia Kenyon, a researcher in biology and genetics who comes ...

    Comment?

  2. Google 'anti-aging' group has a websiteRead the original story w/Photo

    Wednesday Aug 13 | Yahoo!

    ... not been previously announced, include Hall Barron former chief medical officer of pharmaceutical group Hoffmann-La Roche; David Botstein, a Princeton University genomics professor; and Cynthia Kenyon, a researcher in biology and genetics who comes ...

    Comment?

  3. Google opens 'anti-ageing' websiteRead the original story

    Tuesday Aug 12 | Bangkok Post

    ... not been previously announced, include Hall Barron former chief medical officer of pharmaceutical group Hoffmann-La Roche; David Botstein, a Princeton University genomics professor; and Cynthia Kenyon, a researcher in biology and genetics who comes ...

    Comment?

  4. Google's Company That Wants To Cure Death Now Has Its Own WebsiteRead the original story w/Photo

    Tuesday Aug 12 | Silicon Alley Insider

    ... he'll be joined by Hal Barron, former executive VP and chief medical officer of pharmaceutical company Hoffmann-La Roche; "Understanding the fundamental science underlying aging and finding cures for the intractable diseases associated with aging ...

    Comment?

  5. Indranil Mitra, Ph.D., '07 Wins Prestigious Humboldt Postdoctoral Research FellowshipRead the original story

    Friday Aug 8 | Hispanic Business

    ... have any apparent weaknesses." After graduation from ESU, Mitra worked in the toxicology division at Hoffmann-La Roche in . Analytical chemistry is the field of measuring chemical components in natural and synthetic materials. With the development ...

    Comment?

  6. RainDance Technologies Appoints Kathy Ordonez to Board of DirectorsRead the original story

    Wednesday Jul 23 | Hispanic Business

    She joined became the leading producer of genetic testing products for HIV resistance, cystic fibrosis and high complexity tissue transplantation.

    Comment?

  7. China Insulin Delivery Devices Market 2006-2019Read the original story

    Wednesday Jul 23 | Customer Interaction Solutions

    ... Companies Mentioned - Animas Corporation - Becton, Dickinson and Company - Eli Lilly and Company - F. Hoffmann-La Roche Ltd - Medtronic, Inc. - Novo Nordisk A/S - Sanofi-Aventis - Smiths Medical - Terumo Medical Corporation For more information ...

    Comment?

  8. Roche Donates 300 Computes to NJ Community Development Corp.Read the original story

    Jul 16, 2014 | The Alternative Press

    Hoffmann-La Roche Inc. has donated 300 computers to the New Jersey Community Development Corporation , a private, non-profit community development and social service agency whose mission is to create opportunities to transform lives.

    Comment?

  9. RainDance Technologies Appoints Kathy Ordo ez to Board of DirectorsRead the original story

    Jul 16, 2014 | Freshnews

    RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the appointment of Kathy Ordonez to its Board of Directors.

    Comment?

  10. RainDance Technologies Appoints Kathy Ordo ez to Board of DirectorsRead the original story

    Jul 16, 2014 | Hispanic Business

    Kathy Ordoez brings more than 30 years of experience in the life sciences and diagnostics industries.

    Comment?

  11. Covance Announces Senior-Level Appointments to Clinical Development ServicesRead the original story

    Jul 11, 2014 | Biopharm

    ... strategy for the oncology and hematology therapeutic areas. Before joining Covance, Wasserman worked at Hoffmann-La Roche as site head of academic alliances, Pharma Research and Early Development for the Translational Clinical Research Center. ...

    Comment?

  12. People on the MoveRead the original story w/Photo

    Jul 10, 2014 | Drug Researcher

    ... Before joining Covance, Wasserman worked for 15 years in the pharmaceutical industry, most recently at Hoffmann-La Roche as Site Head of Academic Alliances, Pharma Research and Early Development (pRED) for the Translational Clinical Research Center. ...

    Comment?

  13. US Insulin Delivery Devices Market Trends Forecast To 2019Read the original story

    Jun 27, 2014 | Customer Interaction Solutions

    ... Companies Mentioned: - Animas Corporation - Becton, Dickinson and Company - Eli Lilly and Company - F. Hoffmann-La Roche Ltd - Medtronic, Inc. - Novo Nordisk A/S - Sanofi-Aventis - Smiths Medical - Terumo Medical Corporation For more information ...

    Comment?

  14. US Blood Glucose Monitoring Systems Market Market Trends Forecast To 2019Read the original story

    Jun 27, 2014 | Customer Interaction Solutions

    ... Appendix Companies Mentioned: - Abbott Laboratories - Apex Biotechnology Corp - Bayer HealthCare AG - F. Hoffmann-La Roche Ltd - LifeScan, Inc. - Medtronic, Inc. - Terumo Medical Corporation For more information visit ...

    Comment?

  15. Theravance, Inc. Appoints As Senior Vice President, Corporate Partnerships, CommercialRead the original story

    Jun 13, 2014 | BioSpace

    ... industry, Mr. Abercrombie joins Theravance after serving as the President and Chief Executive Officer of Hoffmann-La Roche Inc. from 2001 to 2009 where he was responsible for the U.S. and Canada. Prior to that, Mr. Abercrombie worked at Glaxo and ...

    Comment?

  16. Theravance, Inc. Appoints George B. Abercrombie as Senior Vice...Read the original story

    Jun 12, 2014 | Freshnews

    ... industry, Mr. Abercrombie joins Theravance after serving as the President and Chief Executive Officer of Hoffmann-La Roche Inc. from 2001 to 2009 where he was responsible for the U.S. and Canada. Prior to that, Mr. Abercrombie worked at Glaxo and ...

    Comment?

  17. Guest Post -- Obvious To Try My Patience: Federal Circuit's...Read the original story

    Jun 10, 2014 | JD Supra

    ... The CAFC affirmed (2:1) a New Jersey district court's summary judgment ruling that patents owned by Hoffmann-La Roche covering BonivaA , its once-a-month drug for treating osteoporosis, were invalid under 35 U.S.C. A 103. Ibandronate, a ...

    Comment?

  18. Roche claims pollution from decaying sewer may cost Clifton $10 million, report saysRead the original story

    Jun 10, 2014 | The Jersey Journal

    ... that a pharmaceutical company claims came from Clifton's decaying sewer system, according to the Record. Hoffmann-La Roche, which shutdown its Clifton and Nutley operations in December, conducted an analysis of the city sewer and found chemical ...

    Comment?

  19. Company says sewer line damage could cost the city more than $10 millionRead the original story

    Jun 9, 2014 | The Item

    The pharmaceutical giant Hoffmann-La Roche says Clifton may be liable to pay more than $10 million for a cleanup of groundwater contaminants that have been leaking through a decaying sewer line underneath the company's facility.

    Comment?

  20. Terminal DoseRead the original story

    Apr 14, 2014 | Patent Prospector

    Hoffmann-La Roche got 7,718,634 & 7,410,957 , which claimed a dosing regime for treating osteoporosis.

    Comment?